Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator

Reactive immunization with a single-dose cholera vaccine that could rapidly (within days) protect immunologically naive individuals during virgin soil epidemics, when cholera reaches immunologically naive populations that have not experienced cholera for decades, would facilitate cholera control. On...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Vaccine Immunol
Main Authors: Sow, Samba O., Tapia, Milagritos D., Chen, Wilbur H., Haidara, Fadima C., Kotloff, Karen L., Pasetti, Marcela F., Blackwelder, William C., Traoré, Awa, Tamboura, Boubou, Doumbia, Moussa, Diallo, Fatoumata, Coulibaly, Flanon, Onwuchekwa, Uma, Kodio, Mamoudou, Tennant, Sharon M., Reymann, Mardi, Lam, Diana F., Gurwith, Marc, Lock, Michael, Yonker, Thomas, Smith, Jonathan, Simon, Jakub K., Levine, Myron M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2017
Assuntos:
Vaccines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5717191/
https://ncbi.nlm.nih.gov/pubmed/29021299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00265-17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados